Table 2 Mortality (m), mortality rate (MR, per 100 patient-years) in NT-proBNP tertiles, and mortality rate ratio per tertile increase in NT-proNBP

Gender

2.4 (1.8-3.3)

Female

6 (16.5)

12 (35)

12 (67)

2.1 (1.3-3.3)

Male

1 (1.9)

8 (39)

18 (51)

2.8 (1.8-4.2)

Age, years

2.3 (1.6-3.2)

<65

1 (5.4)

1 (70)

1 (15)

1.8 (0.49-6.8)

65-74

5 (7.9)

11 (33)

10 (65)

3.3 (1.9-5.6)

≥75

1 (11)

8 (39)

19 (60)

1.7 (1.0-2.8)

BMI, kg/m²

2.3 (1.7-3.2)

<20

2 (9.6)

8 (45)

11 (64)

2.1 (1.2-3.5)

≥20

5 (7.2)

9 (30)

18 (50)

2.5 (1.6-3.7)

History of DM

2.4 (1.7-3.2)

No

6 (7.6)

16 (33)

29 (57)

2.4 (1.7-3.3)

Yes

1 (8.8)

4 (21)

1 (44)

2.6 (0.8-8.4)

Cephalization

2.0 (1.4-2.7)

No

7 (8.0)

19 (37)

13 (31)

1.9 (1.3-2.8)

Yes

0

1 (30)

17 (150)

2.2 (1.2-4.2)

Atrial fibrillation

2.3 (1.7-3.1)

No

7 (8.0)

19 (36)

24 (50)

2.3 (1.6-3.2)

Yes

0

1 (41)

6 (109)

2.3 (0.95-5.6)

Peripheral edema

2.3 (1.7-3.1)

No

5 (6.4)

15 (32)

17 (38)

2.2 (1.5-3.2)

Yes

2 (17)

5 (68)

13 (146)

2.4 (1.5-4.1)

SaO₂ <90%

2.3 (1.7-3.1)

No

5 (6.8)

12 (33)

17 (50)

2.5 (1.7-3.8)

Yes

2 (12)

8 (42)

13 (68)

1.9 (1.2-3.2)

CRP, mg/L

2.4 (1.7-3.2)

<50

6 (8.2)

13 (50)

13 (38)

2.0 (1.4-3.1)

≥50

1 (6.0)

7 (24)

17 (90)

3.0 (1.8-5.1)

hs-cTnT, ng/L

1.8 (1.3-2.5)

<14

2 (4.3)

1 (10)

0

0.83 (0.18-3.9)

14-40

4 (12)

10 (30)

10 (71)

2.5 (1.5-4.4)

≥40

1 (10)

9 (78)

20 (67)

1.5 (0.94-2.3)

All, crude MRR

7 (7.8)

20 (36)

30 (56)

2.4 (1.7-3.2)